Serum Folate and Risk for Ischemic Stroke: First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Background and Purpose A serum folate concentration ≤9.2 nmol/L has been associated with elevated levels of plasma homocyst(e)ine. Elevated homocyst(e)ine levels have been associated with ischemic stroke in case-control studies; however, the results from prospective studies have been equivocal. We investigated whether a folate concentration ≤9.2 nmol/L was associated with ischemic stroke in a national cohort. Methods We used data from the First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study (n=2006). Cox proportional hazards analyses were used to adjust for differences in follow-up time and covariates. During the 13-year follow-up, 98 ischemic strokes occurred. Results After adjusting for age, race, sex, education, diabetes, history of heart disease, systolic blood pressure, body mass index, hemoglobin level, cigarette smoking, and alcohol intake, participants with a folate concentration ≤9.2 nmol/L were at slightly increased risk for ischemic stroke (relative risk [RR], 1.37; 95% confidence interval [CI], 0.82 to 2.29). There was a folate-race interaction ( P =.11 for interaction term). Whites with a folate concentration ≤9.2 nmol/L had a relative risk of 1.18 (95% CI, 0.67 to 2.08), whereas blacks had a relative risk of 3.60 (95% CI, 1.02 to 12.71). Conclusions These findings suggest that a folate concentration ≤9.2 nmol/L may be a risk factor for ischemic stroke, especially in blacks. However, given the small number of stroke events, additional studies are needed to assess the role of folate in the epidemiology of ischemic stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972
Cited by
Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence
Eikelboom, J. W., Lonn, E., Genest, J., Hankey, G., & Yusuf, S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-5-199909070-00008 · Cited by 908
Kruman, I. I., Culmsee, C., Chan, S. L., Kruman, Y., Guo, Z., Penix, L., & Mattson, M. P. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-18-06920.2000 · Cited by 784
“Homocysteine levels vary considerably among individuals, and reduced dietary intake of folate is associated with increased homocysteine levels and increased risk for heart disease and stroke (Giles et al., 1995).”
BackgroundThe controversy over homocysteine and cardiovascular risk
Ueland, P. M., Refsum, H., Beresford, S. A., & Vollset, S. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.2.324 · Cited by 517
Homocysteine and cardiovascular disease: cause or effect?
Brattström, L., & Wilcken, D. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.2.315 · Cited by 439
Duan, W., Ladenheim, B., Cutler, R. G., Kruman, I. I., Cadet, J. L., & Mattson, M. P. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00676.x · Cited by 405
Homocyst(e)ine and Risk of Cardiovascular Disease in the Multiple Risk Factor Intervention Trial
Evans, R. W., Shaten, B. J., Hempel, J. D., Cutler, J. A., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.1947 · Cited by 342
Folates and Cardiovascular Disease
Verhaar, M. C., Stroes, E., & Rabelink, T. J. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0102.102190 · Cited by 291
De Backer, G., Ambrosioni, E., Broch-Johnsen, K., Brotons, C., Cifkova, R., Dallongeville, J., Ebrahim, S., Faergeman, O., Graham, I., Mancia, G., et al. (2003) · European Journal of Cardiovascular Prevention and Rehabilitation · doi:10.1097/00149831-200312001-00001 · Cited by 274
Folate, homocysteine, endothelial function and cardiovascular disease
Moat, S. J., Lang, D., McDowell, I. F. W., Clarke, Z. L., Madhavan, A. K., Lewis, M. J., & Goodfellow, J. (2004) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2003.08.010 · Cited by 261
Impaired Homocysteine Metabolism and Atherothrombotic Disease
Durand, P., Prost, M., Loreau, N., Lussier-Cacan, S., & Blache, D. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780275 · Cited by 261
Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial
Brouwer, I. A., van Dusseldorp, M., Thomas, C. M., Duran, M., Hautvast, J. G., Eskes, T. K., & Steegers-Theunissen, R. P. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.1.99 · Cited by 245
The Role of Homocysteine‐Lowering B‐Vitamins in the Primary Prevention of Cardiovascular Disease
Debreceni, B., & Debreceni, L. (2014) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12064 · Cited by 116
Serum Folate and Cardiovascular Disease Mortality Among US Men and Women
Loria, C. M., Ingram, D. D., Feldman, J. J., Wright, J. D., & Madans, J. H. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3258 · Cited by 98
Metadata
- Authors
- Giles, W. H., Kittner, S. J., Anda, R. F., Croft, J. B., & Casper, M. L.
- Venue
- Stroke
- Published
- 1995-07
- Volume
- 26
- Issue
- 7
- Pages
- 1166-1170
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2035023347
- Cited by
- 123
- References
- 1
- FWCI
- 5.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.